Amended Annual Report (10-k/a)
October 25 2013 - 6:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-K/A
x
ANNUAL
REPORT UNDER SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934:
For the fiscal year ended June 30,
2013
¨
TRANSITION
REPORT UNDER SECTION 13 OR 15 (d) OF THE EXCHANGE ACT OF 1934
Commission file number:
333-128226
INTELLECT NEUROSCIENCES, INC.
(Exact name of registrant as specified in
its charter)
Delaware
|
|
|
(State or other jurisdiction of
|
|
20-8329066
|
incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
550 Sylvan Ave.
|
|
|
Englewood Cliffs, NJ
|
|
07632
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(201) 608 5101
(Registrant’s telephone number, including
area code)
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned
issuer, as defined in Rule 405 of the Securities Act:
Yes
¨
No
x
Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes
¨
No
x
Indicate
by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes
x
No
¨
Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes
¨
No
¨
Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and
will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated
by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
x
Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
Large accelerated filer
¨
|
Accelerated filer
¨
|
Non-accelerated filer
¨
|
Smaller reporting company
x
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
¨
No
x
As of December 31, 2012, the last business day of the registrant’s
most recently completed second quarter, the aggregate market value of the shares of common stock held by non-affiliates of the
registrant was $1,079,900 based on the closing price of the registrant’s common stock on that date.
As of October 15, 2013, there were 285,818,121 shares of common
stock issued and outstanding.
EXPLANATORY NOTE
Intellect Neuroscience’s Inc. (the
“Registrant”) filed its Annual Report on Form 10-K for the fiscal year ended June 30, 2013 on October 15, 2013. The
Registrant is filing this Amendment No. 1 on Form 10-K/A to furnish its Interactive Data Files (XBRL Exhibits) as Exhibit 101.
Users of this data are advised that pursuant
to Rule 405 of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus
for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of section 18 of
the Securities and Exchange Act of 1934, and otherwise are not subject to liability under those sections.
Investors should continue to rely on the
originally filed version of the Form 10-K. No other changes have been made to the Form 10-K other than those described above. This
Amendment No. 1 on Form 10-K/A does not reflect subsequent events occurring after the original filing date of the Form 10-K or,
except as described above, modify or update any disclosures made in the Form 10-K.
SIGNATURES
Pursuant to the requirements of Section
13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
In accordance with the Securities Exchange
Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on
the dates indicated:
Dated: October 25, 2013
|
INTELLECT NEUROSCIENCES, INC.
|
|
|
|
|
|
/s/ Elliot Maza
|
|
Elliot Maza
|
|
Principal Executive Officer and Consulting Chief Financial Officer (Principal Financial and Accounting Officer)
|
SIGNATURES
|
|
TITLE
|
|
DATE
|
|
|
|
|
|
/s/ Elliot Maza
|
|
|
|
|
|
|
Principal Executive Officer
|
|
|
Elliot Maza
|
|
Consulting CFO and Director
|
|
October 25, 2013
|
|
|
(Principal Financial and Accounting Officer)
|
|
|
|
|
|
|
|
/s/ Isaac Onn
|
|
|
|
|
|
|
|
|
|
Isaac Onn
|
|
Director
|
|
October 25, 2013
|